Target intelligence / Profile preview

Gastrointestinal epithelial barrier function

Molecular classification
Other (not a single molecule, receptor, or protein; refers to a physiological property of tissue)
01

Overview

The **gastrointestinal epithelial barrier** is not a single molecular target but rather an integrated physiological system formed primarily by sheets of tightly joined epithelial cells lining the digestive tract. This structure serves as a critical interface between the body and potentially harmful luminal contents—including toxins, pathogens, and antigens—while allowing selective absorption of nutrients and water. The integrity of this barrier depends on several components: *Physical elements*: Tight junctions between adjacent cells regulate paracellular transport; specialized cell types such as goblet cells secrete mucus that forms an additional protective layer over the epithelium; commensal microbiota contribute both directly and indirectly to maintaining homeostasis. *Immune elements*: Underlying immune cells provide surveillance against invading pathogens while limiting unnecessary inflammation. Disruption or dysfunction of this complex system has been implicated in numerous diseases including inflammatory bowel disease, irritable bowel syndrome, food allergies, metabolic syndrome/diabetes, infections, celiac disease, non-alcoholic fatty liver disease, among others. While therapies such as probiotics or zinc supplementation may help restore normal function in certain contexts by enhancing tight junction integrity or modulating immune responses/microbiota composition,[1][2][3][4][5] "gastrointestinal epithelial barrier function" itself does not refer to a discrete druggable target like an enzyme or receptor—it describes an emergent property arising from multiple cellular components working together.[1] Therefore it should be classified as *not* being a canonical therapeutic target molecule/receptor.

Other names
Gastrointestinal barrierIntestinal mucosal barrierIntestinal epithelial barrierGI epithelial barrier
02

Mechanism of action

Probiotics—modulate gut microbiota, improve tight junction integrity, reduce inflammation, restore mucus layer function[5] Zinc—may enhance tight junction protein expression and reduce permeability in some contexts[2]

03

Biological functions

Barrier to toxins and microorganisms[1][3][5]Regulation of intestinal permeability[2][3][5]Absorption of nutrients and electrolytes[2][3]Immune defense[2][3][5]
04

Disease associations

Inflammation (e.g., inflammatory bowel disease)[2][3]Infection[3]Metabolic syndrome/diabetes[2][3]Food allergies/celiac disease[3]Irritable bowel syndrome/functional gastrointestinal disorders[2][4]
05

Safety considerations

Therapeutic interventions aimed at modulating the gastrointestinal epithelial barrier may risk altering nutrient absorption or immune responses. Over-correction could theoretically lead to malabsorption or increased susceptibility to infection if the balance is disrupted.
06

Interacting drugs

Probiotics (e.g., Saccharomyces boulardii)[4]

2 more in the full profile.

07

Biomarkers

Increased intestinal permeability ("leaky gut") as measured by lactulose/mannitol test or other assays is used as a biomarker for dysfunction but not specific to this "target"[6].

Beyond the preview

Go deeper on Gastrointestinal epithelial barrier function.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastrointestinal epithelial barrier function.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call